Please use this identifier to cite or link to this item:
Title: Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Antineoplastic Combined Chemotherapy Protocols/therapeutic use,Breast Neoplasms/*drug therapy/genetics/metabolism,Chemotherapy, Adjuvant,Clinical Trials, Phase III as Topic,Cluster Analysis,Disease-Free Survival,Dose-Response Relationship, Drug,Estrogen Receptor alpha/genetics/metabolism,Estrogen Receptor beta/genetics/metabolism,Female,Gene Expression Regulation, Neoplastic,Humans,Immunohistochemistry,Middle Aged,Outcome Assessment (Health Care)/methods,Phenotype,Prognosis,Randomized Controlled Trials as Topic,Receptor, erbB-2/genetics/*metabolism,Receptors, Estrogen/genetics/*metabolism,Receptors, Progesterone/genetics/*metabolism,Reverse Transcriptase Polymerase Chain Reaction,Translational Medical Research/methods,Young Adult
ISSN: 1432-0843
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Skarlos-2012-Triple-negative phen.pdf992.08 kBAdobe PDFView/Open    Request a copy

This item is licensed under a Creative Commons License Creative Commons